Teva Coreg Damages Reinstated As AAM Bemoans ‘Antithetical’ Ruling

Israeli Firm Is On Hook Again For $235m Payment

 
• By Dean Rudge
  
Gavel_Money
Teva is facing the prospect of nearly a quarter of a billion of dollars of damages once again • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Legal & IP

More from Generics Bulletin